EGF61A>G polymorphism as predictive marker of clinical outcome to first-line capecitabine and oxaliplatin in metastatic colorectal cancer - Concepedia

Concepedia

Publication | Closed Access

EGF61A>G polymorphism as predictive marker of clinical outcome to first-line capecitabine and oxaliplatin in metastatic colorectal cancer

29

Citations

19

References

2009

Year

K.-L.G. Spindler, Rikke Fredslund Andersen, Lars Henrik Jensen, Anders Jakobsen

Annals of Oncology

G PolymorphismFirst-line CapecitabineMedicineColorectal CancerPathologyMetastatic Colorectal CancerCancer GenomicsMolecular OncologyCancer GeneticsOncologyRadiation OncologyCancer Research

References

	Year	Citations

Page 1